BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  AbbVie Eyes Regulatory Approval for Atogepant After Positive Phase III Migraine Study

  Atogepant, an oral CGRP receptor antagonist, is an experimental migraine treatment AbbVie gained through its acquisition of Allergan.

  July 30, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Biopharma Update on the Novel Coronavirus: July 31

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 31, 2020.

  July 30, 2020

   · 

  4 min read

   · 

  BioSpace Editorial Staff
• 

  Bio NC

  Research Roundup: Can Flu and Pneumonia Vaccines Prevent Alzheimer’s and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  July 30, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure

  Boehringer Ingelheim and Eli Lilly and Company announced that the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes, met the primary endpoint.

  July 30, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Genentech Cuts 474 Jobs in Move Not Related to COVID-19 Programs

  Genentech is eliminating 474 employees, mostly based out of its South San Francisco facilities. The job cuts are expected to be permanent.

  July 30, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  3 Tips for Writing an ATS-Friendly Resume

  If you are looking for a new job, it is crucial to have an ATS friendly resume. Let’s discuss how to do this and why they’re so popular with hiring managers.

  July 30, 2020

   · 

  3 min read

   · 

  Laura Brothers
• 

  Drug Development

  How an AI-Powered Phone App is Helping Participants During Clinical Trials

  AiCure’s phone app helps clinical trials keep tabs on which participants have taken their medications correctly and which have not. By analyzing videos the app takes, they can also spot who is intentionally not taking their pills, known as intentional nonadherence.

  July 30, 2020

   · 

  6 min read

   · 

  Chelsea Weidman Burke
• 

  Business

  BioSpace Movers & Shakers, July 31

  Biopharma and life science companies strengthen their leadership teams and board with these Movers & Shakers.

  July 30, 2020

   · 

  6 min read

   · 

  Alex Keown
• 

  Business

  AAIC 2020: Multi-omics and Biomarkers Emerge as Key Elements in the Future of Alzheimer’s Research

  A multi-omics, multi-algorithm approach will unleash a new wave of understanding around Alzheimer’s disease and diagnosis, that in time, will make precision diagnostics practical, speakers predicted at the Alzheimer’s Association International Conference 2020.

  July 30, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  Sangamo and Novartis Enter Agreement to Focus on Neurodevelopmental Diseases

  Genomic medicine company Sangamo Therapeutics announced today that it has entered a global licensing collaboration agreement with Novartis to develop and commercialize gene regulation therapies for three neurodevelopmental targets, including autism spectrum disorder.

  July 30, 2020

   · 

  3 min read

   · 

  Krystle Vermes